Delivery Order SPE2DB20D3103-SPE2DB25FP8E7
- Not listed
- The Defense Logistics Agency awarded a $4,722.81 delivery order to AmerisourceBergen Drug Corp for the supply of Hydromorphone 1 mg/ml on September 11, 2025, with completion targeted for September 12, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml on June 18, 2025, with a ceiling value of $1,103.20 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with performance scheduled to conclude by June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,144.88 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Hydromorphone 2 mg/ml, a narcotic pain management pharmaceutical. This firm fixed-price delivery order, which is expected to be completed by August 29, 2025, carries no set-aside designation and represents a competitively awarded transaction under open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,127.10 to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml, a controlled pharmaceutical used in pain management and palliative care. Issued on July 21, 2025, with an ultimate completion date of July 22, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Hydromorphone 1 mg/ml with a ceiling value of $1,447.00. This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by April 23, 2025. The award is being fulfilled from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.20 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $96,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 10 mg/ml vials of hydromorphone. The single day contract has a period of performance from September 27 through September 28, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order falls under a larger blanket purchase...
- The Defense Logistics Agency Troop Support Medical awarded a $512 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562172828, described as Hydromorphone 50 mg/5 ml vials (5 ml). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 14-15, 2023. No set aside designation or subcontractors were indicated. This delivery order was issued under an existing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Hydromorphone HCL ER Tablets 16mg, with a contract ceiling value of $6,259.66 and a completion date of August 5, 2025. This competitive award, made without set-aside designation, is classified as a firm fixed price delivery order and represents a continuation of the federal government's ongoing pharmaceutical procurement through established...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at sixty-one thousand three hundred thirty-five dollars to Amerisourcebergen Drug Corporation for one hundred tablets of four milligram hydromorphone. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is one day, from June 22nd to June 23rd, 2023. The Defense Logistics Agency procures pharmaceuticals and medical supplies to support the United...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8E7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,621.71 to AmerisourceBergen Drug Corp for the supply of Hydromorphone 1 mg/ml on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Hydromorphone is an opioid pain medication commonly used in military and veteran healthcare systems for pain management across the Defense Health System. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp has demonstrated significant capability in meeting federal medical procurement requirements through open competition, serving critical federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/11/25 |